-
$0
0.0% of portfolio
-
Q3 2023
Reduced 51.04%
$37.2B
$942,000
0.0% of portfolio
47,203
Q1 2024
Reduced 43.76%
$7.87B
$2.1 Million
0.0% of portfolio
64,612
Q4 2022
Added 39.08%
$1.36B
$515,000
0.0% of portfolio
23,468
Q1 2024
Added 25.55%
$2.3B
$222,000
0.0% of portfolio
3,576
Q1 2024
Reduced 88.34%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 81.9%
$1.59B
$271,000
0.0% of portfolio
18,114
Q1 2024
Added 2.17%
$2.25B
$342,000
0.0% of portfolio
7,951
Q1 2024
Reduced 2.79%
$1.81B
$1.2 Million
0.0% of portfolio
66,915
Q1 2024
Added 3.23%
$7.12B
$993,000
0.0% of portfolio
129,400
Q1 2024
Added 83.03%
-
$0
0.0% of portfolio
-
Q1 2024
Added 3.23%
$672M
$163,000
0.0% of portfolio
34,027
Q1 2024
Added 93.04%
$637M
$1.31 Million
0.0% of portfolio
216,776
Q1 2024
Reduced 32.46%
$39.8M
$366,000
0.0% of portfolio
358,906
Q1 2023
New
$8.06B
$391,000
0.0% of portfolio
8,018
Q1 2024
Added 15.32%
-
$0
0.0% of portfolio
-
Q1 2023
Added 15.33%
$2.98B
$1.5 Million
0.0% of portfolio
137,620
Q1 2024
Reduced 4.17%
$6.52B
$3.19 Million
0.0% of portfolio
73,467
Q1 2024
Added 0.73%
$16.8B
$649,000
0.0% of portfolio
31,038
Q1 2024
Added 32.01%
$752M
$1.05 Million
0.0% of portfolio
91,790
Q1 2024
Added 22.54%
$4.94B
$2.32 Million
0.0% of portfolio
144,418
Q1 2024
Reduced 2.1%
-
$0
0.0% of portfolio
-
Q3 2023
Reduced 60.5%
$1.19B
$2.22 Million
0.0% of portfolio
243,821
Q1 2024
Reduced 31.19%
$334M
$203,000
0.0% of portfolio
16,417
Q1 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 44.75%
$2.34B
$1.69 Million
0.0% of portfolio
51,206
Q1 2024
Added 1.27%
$3.98B
$2.11 Million
0.0% of portfolio
77,942
Q1 2024
Added 10.14%
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 1.55%
$1.9B
$1.48 Million
0.0% of portfolio
20,555
Q1 2024
New
$1.87B
$951,000
0.0% of portfolio
82,765
Q1 2024
Reduced 1.52%
$1.08B
$239,000
0.0% of portfolio
11,778
Q1 2024
New
$24.6M
$57,000
0.0% of portfolio
17,276
Q1 2024
New
$1.39B
$517,000
0.0% of portfolio
33,685
Q1 2024
Added 88.04%
$1.58B
$276,000
0.0% of portfolio
6,497
Q1 2024
New
$293M
$113,000
0.0% of portfolio
19,190
Q1 2024
New
$1.89B
$1.16 Million
0.0% of portfolio
11,271
Q1 2024
Reduced 3.41%
$1.16B
$233,000
0.0% of portfolio
21,430
Q1 2024
Added 0.46%
$1.22B
$537,000
0.0% of portfolio
32,613
Q1 2024
Reduced 18.62%
$1.16B
$422,000
0.0% of portfolio
1,944
Q1 2024
Added 15.58%
$19.1B
$1.74 Million
0.0% of portfolio
13,514
Q1 2024
Reduced 37.94%
$3.31B
$2.49 Million
0.0% of portfolio
252,330
Q1 2024
Added 213.89%
$64.4M
$54,000
0.0% of portfolio
43,138
Q1 2024
New
$47.9M
$15,000
0.0% of portfolio
22,816
Q2 2023
New
$904M
$746,000
0.0% of portfolio
9,928
Q1 2024
Reduced 13.9%
$2.26B
$3.14 Million
0.0% of portfolio
84,317
Q1 2024
Added 58.51%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2023
New
$5.56B
$1.06 Million
0.0% of portfolio
3,189
Q1 2024
Reduced 13.34%
$1.04B
$1.47 Million
0.0% of portfolio
106,484
Q1 2024
Reduced 6.92%
$0
$795,000
0.0% of portfolio
20,058
Q1 2024
Reduced 13.58%